Further studies on the action of 5-hydroxytryptamine on lumbar motoneurones in the rat isolated spinal cord
- 12 Downloads
Using the hemisected spinal cord of the neonate rat, the effects of altered external Ca, thyrotrophin-releasing hormone (TRH) and a number of antagonists were tested on depolarizations evoked by 5-hydroxytryptamine (5-HT). Responses of populations of motoneurones were recorded via a ventral root. 5-Hydroxytryptamine depolarizations were not Ca-dependent but were enhanced in amplitude in Ca-free solutions. Raised Mg reversed this enhancement. 5-Hydroxytryptamine depolarizations persisted in the presence of Mn (1.53 mmol/l). TRH depolarized motoneurones; there was no evidence of modulation of 5-HT responses on concurrent application of TRH. Ritanserin (0.1 μmol/l) had a modest blocking action on 5-hydroxytryptamine depolarizations reducing the maximum; 1μmol/l ritanserin caused a greater antagonism which was unsurmountable (pIC50 5.2). Ritanserin (0.1 or 1 μmol/l) did not depress responses to noradrenaline (NA). Ketanserin (0.1 μmol/l) caused a blockade of slow onset, equilibrium with the receptors requiring 1 h. Blockade by 0.01, 0.1 and 1 μmol/l ketanserin was concentration-dependent (pIC50 6.2). Ketanserin 1 μmol/l, but not at lower concentrations, depressed noradrenaline responses. Mianserin (0.1 μmol/l) also caused a blockade of slow onset; 0.1 or 1 μmol/l produced a flattening of the 5-hydroxytryptamine concentration-response curve but did not depress noradrenaline responses (pIC50 4.7). The pIC50 for spiperone was 8.0. DOI (10–100 μmol/l) had no detectable agonist action but at concentrations of 0.01 and 0.1 μmol/l it acted as an antagonist. Equilibration with the receptors occurred over 2 h. DOI (0.01 μmol/l) depressed 5-hydroxytryptamine but not noradrenaline responses; higher concentrations of DOI also depressed noradrenaline responses. The pharmacological profile of the 5-hydroxytryptamine receptor mediating depolarization of spinal and facial motoneurones suggests that it belongs to the 5-HT1C-5-HT2, group of 5-hydroxytryptamine receptors but is not identical to 5-HT1C or the 5-HT2 CNS binding sites. Alternatively, the response might arise from a mixed population of 5-HT1-like and 5-HT2 receptors.
Key words5-Hydroxytryptamine Motoneurones Isolated spinal cord Neonate rat
Unable to display preview. Download preview PDF.
- Aghajanian GK (1981) The modulatory role of serotonin at multiple receptors in brain. In: Jacobs BL, Gelperin A (eds) Serotonin neurotransmission and behaviour. MIT Press, Cambridge, Mass, pp 156–185Google Scholar
- Elliott P, Wallis DI (1990) The action of 5-hydroxytryptamine on lumbar motoneurones in neonatal rat spinal cord in vitro. J Physiol 426:54PGoogle Scholar
- Hoyer D (1989) 5-Hydroxytryptamine receptors and effector coupling mechanisms in peripheral tissues. In: Fozard JR (ed) Peripheral actions of 5-hydroxytryptamine. Oxford University Press, Oxford, pp 72–99Google Scholar
- Johansson O, Hökfelt T, Pernow B, Jeffcoate SL, White N, Steinbusch HWM, Verhofstad GAJ, Emson PC, Spindel E (1981) Immunohistochemical support for three putative trans mitters in one neurone: co-existence of 5-hydroxytryptamine, substance P and thyrotropin releasing hormone-like immune-reactivity in medullary neurons projecting to the spinal cord. Neuroscience 6:1857–1881CrossRefGoogle Scholar
- Larkman PM, Kelly JS (1990a) 5-HT and noradrenaline-evoked depolarization of rat facial motoneurones. in vitro: mediated through K+ channel closure. Neurosci Lett 38:S117Google Scholar
- Larkman PM, Kelly JS (1990b) The action of 5-carboxamidotryptamine (5-CT) on adult rat facial motoneurones in vitro differentiates two distinct depolarizing actions of 5-hydroxytryptamine (5-HT). Br J Pharmacol (in press)Google Scholar
- Pierce PA, Peroutka SJ (1988) Indolealkylamines and phenalkylamines have opposite effects on phosphatidylinositol hydrolysis in rat cortex. See Neurosci Abstr. 14:610Google Scholar
- Rasmussen K, Aghajanian GK (1988) Serotonin excitation of facial motoneurones: mediation through a 5-HT2 receptor. Soc Neurosci Abstr 14:610Google Scholar
- Schechter LE, Consigny PM, Simansky KJ (1988) 1-(2,5-dimethoxy-4-iodo phenyl)-2-aminopropane (DOI) acts at 5-HT2 receptors to contract the portal vein in vitro and inhibit feeding in vivo. Soc Neurosci Abstr 14:610Google Scholar